MEDISENSE OPTIUM
Report
- Report Number
- 2954323-2011-00683
- Event Type
- Malfunction
- Date Received
- January 14, 2011
- Date of Event
- December 1, 2010
- Report Date
- January 14, 2011
- Product Code
- NBW
- Removal / Correction Number
- ADC FA1197-2010
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
RETAIN SAMPLES OF PRECISION TEST STRIP LOTS MANUFACTURED WITH HOT-MELT GLUE BATCHES EXHIBITED LOWER THAN EXPECTED READINGS ON CONTINUOUS STORAGE AFTER NINE MONTHS AT 30C DURING ROUTINE STABILITY PERFORMANCE TESTING. THIS STABILITY ISSUE COULD LEAD TO THE GENERATION OF INCORRECTLY DEPRESSED BLOOD GLUCOSE RESULTS AND THESE ERRONEOUS RESULTS MAY BE IN THE C, D OR E ZONES OF PARKES ERROR GRID, AND AS SUCH, HAVE THE POTENTIAL TO BE CLINICALLY SIGNIFICANT. THE PRIMARY CAUSE HAS BEEN IDENTIFIED TO BE BATCH TO BATCH GLUE VARIABILITY. THE FDA HAS BEEN INFORMED OF THE FIELD ACTION PER 21CFR806 (FIELD ACTION REFERENCE NUMBER 2954323-12/22/10-001-R). ALL AFFECTED CONSIGNEES WERE NOTIFIED BY LETTER BEGINNING DECEMBER 22, 2010.
IN USING AN AFFECTED TEST STRIP RELATED TO AN ON-GOING FIELD ACTION FOR ABBOTT'S PRECISION FAMILY TEST STRIPS, THE CUSTOMER REPORTED EITHER LONGER BLOOD FILL TIME OR READINGS ISSUES. SPECIFICALLY, THE CUSTOMER REPORTED RECEIVING READINGS OF 212MG/DL,194MG/DL AND 186MG/DL ON (B)(6) 2010 HOWEVER, THE CUSTOMER COULD NOT RECALL THE EXACT TIMES THE READINGS WERE OBTAINED. CUSTOMER STATED THEY EXPERIENCED SYMPTOMS OF "FATIGUE, THIRST AND A LOSS OF APPETITE" AND FURTHER REPORTED THEY DECREASED THEIR INSULIN DOSAGE BASED ON THE READINGS. NO THIRD PARTY MEDICAL INTERVENTION WAS REPORTED AND CUSTOMER DENIED SELF-TREATMENT FOR THEIR SYMPTOMS. THERE WAS NO REPORT OF SERIOUS INJURY, DEATH OR PERMANENT IMPAIRMENT ASSOCIATED WITH THIS REPORT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MEDISENSE OPTIUM | BLOOD GLUCOSE MONITORING SYSTEM | NBW | 45841 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |